- Home
- ILPT vs NAUT Comparison
ILPT vs NAUT Comparison
Compare ILPT & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ILPT | NAUT |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.9M | 383.5M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ILPT | NAUT |
|---|---|---|
| Price | $7.33 | $2.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $7.05 | $4.00 |
| AVG Volume (30 Days) | ★ 324.0K | 312.1K |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.79% | N/A |
| EPS Growth | ★ 31.51 | 16.07 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.04 | N/A |
| Revenue Next Year | $2.18 | $992.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.77 | $0.62 |
| 52 Week High | $7.76 | $4.31 |
Technical Indicators
Market Signals| Indicator | ILPT | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 73.73 | 40.21 |
| Support Level | $5.10 | $1.82 |
| Resistance Level | N/A | $3.18 |
| Average True Range (ATR) | 0.31 | 0.24 |
| MACD | 0.18 | -0.09 |
| Stochastic Oscillator | 82.37 | 9.83 |
Price Performance
Historical ComparisonAbout ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.